WHO Reports Records Daily Increase Of Global Coronavirus Cases

There was a record increasing in the global coronavirus cases as shown by WHO reports. As per the report, on Friday, 284,196 fresh COVID-19 cases were reported in 24 hours.

Friday recorded the biggest single-day increases in deaths due to the COVID-19. Last single-day highest death numbers were reported on April 30 accounting for 9,797 deaths. On Friday, 9,753 deaths due to OVID-19 were recorded.

Previously, on July 18 WHO reported the highest number of global COVD-19 cases which was 259,848. In July, 5,000 deaths have been reported in a single day on an average. However, in June, 4,600 deaths were reported in a single day on an average.

The WHO reports found 69,641 new cases in the US, 67,860 in Brazil, 49,310 in India, and 13,104 in South Africa. The largest increases in new deaths were 3,876 in Peru, 1,284 in Brazil, 1,074 in the United States, 790 in Mexico, and 740 in India.
Peru in a day saw a death toll of 3,000, after recently reviewing its COVID-19 data. A total of 17,000 deaths have been reported in Peru due to the COVID-19.

On July 17, India became the third worst-hit country to record more than 1 Million coronavirus cases. The first rank was held by the U.S. and the second one was Brazil. Epidemiologists say India is still likely months from hitting its peak.

Cases in Brazil crossed the 2 million mark on July 16, doubling in less than a month as the country adds nearly 40,000 new cases a day. A patchwork of state and city responses has held up poorly in Brazil, in the absence of a tightly coordinated policy from the federal government.

The US, which leads the world with over 4 million cases, has also tried to curb the outbreak at the state and local level, with only limited success.

Recently a study conducted in South Korea founded that people are contracting the coronavirus from within their own households rather than contracting from outsiders.

Meanwhile, Covaxin, India’s first developed vaccine against the coronavirus, started its first phase of human trial. The human trial began at Delhi’s AIIMS. The first dose of the injection was given to a 30-year-old man.

Source

Facebook Comments
Aisha Zainab: